Hepatitis E: Current status

Reviews in Medical Virology

Volumn 23, Issue 6, 2013, Pages 384-398

  Pérez Gracia, María Teresa ^a   Mateos Lindemann, María Luísa ^b   Montalvo Villalba, María Caridad ^c  

^a UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; HEPATITIS E ANTIBODY; METHYLTRANSFERASE; PEGINTERFERON ALPHA; RIBAVIRIN; SINGLE STRANDED RNA; SUBUNIT VACCINE;

ABDOMINAL PAIN; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ASTHENIA; BELL PALSY; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; DENMARK; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEVER; FRANCE; GENETIC VARIABILITY; GENOME ANALYSIS; GLYCOSYLATION; GUILLAIN BARRE SYNDROME; HEPATITIS B VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOELECTRON MICROSCOPY; INDIA; JAUNDICE; KYRGYZSTAN; LIVER HISTOLOGY; MEMBRANOUS GLOMERULONEPHRITIS; MENINGOENCEPHALITIS; MONOTHERAPY; MORTALITY; MYANMAR; NONHUMAN; PANCREATITIS; PATHOGENESIS; PERINATAL MORTALITY; PREVALENCE; RADICULOPATHY; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SPAIN; TAXONOMY; THIRD TRIMESTER PREGNANCY; THROMBOCYTOPENIA; UGANDA; UNITED STATES; USSR; VERTICAL TRANSMISSION; VIRUS GENOME; VIRUS LOAD; VIRUS MORPHOLOGY; WATER CONTAMINATION;

CHRONIC DISEASE; DEVELOPED COUNTRIES; DISEASE OUTBREAKS; HEPATITIS E; HUMANS; IMMUNOCOMPROMISED HOST;

EID: 84887172849     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1759     Document Type: Review

References (148)

1. WHO. Viral Hepatitis Statement A62/22. http://apps.who.int/gb/ebwha/pdf.files/A62/A62.22.en.pdf
2. Arankalle VA, Tsarev SA, Chadha MS, et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. Journal of Infectious Diseases 1995; 171: 447-450.
3. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. Journal of Hepatology 2008; 48: 494-503.
4. Perez-Gracia MT, Mateos ML, Galiana C, et al. Autochthonous hepatitis E infection in a slaughterhouse worker. The American Journal of Tropical Medicine and Hygiene 2007; 77: 893-896.
5. Mateos Lindemann ML, Morales JG, Fernández-Barredo S, et al. Fulminant hepatitis E in a woman taking oral contraceptive medication. The American Journal of Tropical Medicine and Hygiene 2010; 82: 12-15.
6. Miyashita K, Kang JH, Saga A, et al. Three cases of acute or fulminant hepatitis E caused by ingestion of pork meat and entrails in Hokkaido, Japan: zoonotic food-borne transmission of hepatitis E virus and public health concerns. Hepatology Research 2012; 42: 870-878.
7. Li TC, Yamakawa Y, Suzuki K, et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. Journal of Virology 1997; 71: 7207-7213.
8. Tam AW, Smith MM, Guerra ME, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991; 185: 120-131.
9. Emerson SU, Purcell RH. Hepatitis E virus. Reviews in Medical Virology 2003; 13: 145-154.
10. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Reviews in Medical Virology 2006; 16: 5-36.
11. Ahmad I, Holla PR, Jameel S. Molecular virology of hepatitis E virus. Virus Research 2011; 161: 47-58.
12. Khudyakov YE, Favorov MO, Khudyakova NS, et al. Artificial mosaic protein containing antigenic epitopes of hepatitis E virus. Journal of Virology 1994; 68: 7067-7074.
13. Berke T, Matson DO. Reclassification of the Caliciviridae into distinct genera and exclusion of hepatitis E virus from the family on the basis of comparative phylogenetic analysis. Archives of Virology 2000; 7: 1421-1436.
14. Emerson SU, Anderson D, Arankalle A, et al. Hepevirus. In Virus Taxonomy, Eighth Report of the International Committee on Taxonomy of Viruses, Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA (ed.). Academic Press: London, United Kingdom, 2004; 851-855.
15. Schlauder GG, Mushahwar IK. Genetic heterogeneity of hepatitis E virus. Journal of Medical Virology 2001; 2: 282-292.
16. Meng XJ, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proceedings of the National Academy of Sciences 1997; 94: 9860-9865.
17. Ward P, Müller P, Letellier A, et al. Molecular characterization of hepatitis E virus detected in swine farms in the province of Quebec. Canadian Journal of Veterinary Research 2008; 72: 27-31.
18. Schlauder GG, Frider B, Sookoian S, et al. Identification of 2 novel isolates of hepatitis E virus in Argentina. Journal of Infectious Diseases 2000; 1: 294-297.
19. Perez-Gracia MT, Garcia-Valdivia MS, Galan F, et al. Detection of hepatitis E virus in patients sera in southern Spain. Acta Virologica 2004; 48: 197-200.
20. Fernandez-Barredo S, Galiana C, Garcia A, et al. Detection of hepatitis E virus shedding in feces of pigs at different stages of production using reverse transcription-polymerase chain reaction. Journal of Veterinary Diagnostic Investigation 2006; 18: 462-465.
21. Mansuy JM, Abravanel F, Miedouge M, et al. Acute hepatitis E in south-west France over a 5-year period. Journal of Clinical Virology 2009; 44: 74-77.
22. Banks M, Bendall R, Grierson S, et al. Human and porcine hepatitis E virus strains, United Kingdom. Emerging Infectious Diseases 2004; 5: 953-955.
23. Worm HC, Schlauder GG, Wurzer H, Mushahwar IK. Identification of a novel variant of hepatitis E virus in Austria: sequence, phylogenetic and serological analysis. Journal of General Virology 2000; 12: 2885-2890.
24. Van der Poel WH, Verschoor F, van der Heide R, et al. Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands. Emerging Infectious Diseases 2001; 6: 970-976.
25. Garkavenko O, Obriadina A, Meng J, et al. Detection and characterisation of swine hepatitis E virus in New Zealand. Journal of Medical Virology 2001; 65: 525-529.
26. WHO. Viral hepatitis in the WHO countries of south-east Asia region. http://209.61.208.233/LinkFiles/Diarrhoea, _ARI_and_hepatitis_hepatitis-E.pdf
27. Panda SK, Thakral D, Rehman, S. Hepatitis E virus. Reviews in Medical Virology 2007; 17: 151-180.
28. Teshale EH, Howard CM, Grytdal SP, et al. Hepatitis E epidemic, Uganda. Emerging Infectious Diseases 2010; 16: 126-129.
29. Viswanathan R. Infectious hepatitis in Delhi (1955-56): a critical study: epidemiology. Indian Journal of Medical Research 1957; 45: 1-29.
30. Zhuang H, Cao XY, Liu CB, et al. Epidemiology of hepatitis E in China. Gastroenterologia Japonica 1991; 26: 135-138.
31. Hepatitis E Wikipedia1. 18 killed in hepatitis E outbreak in Maharashtra. http://india.nydailynews.com/newsarticle/4fe1e6dbb1e35ded2500000/18-killedinhepatitis-e-outbreak-in-maharashtra (2012).
32. McQuillan GM, Townsend TR, Fields HA T, et al. Seroepidemiology of hepatitis B virus infection in the United States. American Journal of Medicine 1989; 87: 5.
33. Fix AD, Abdel-Hamid M, Purcell RH, et al. Prevalence of antibodies to hepatitis E in two rural Egyptian communities. The American Journal of Tropical Medicine and Hygiene 2000; 62: 519-523.
34. Pujol FH, Favorov MO, Marcano T, et al. Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela. Journal of Medical Virology 1994; 42: 234-236.
35. Macedo G, Pinto T, Sarmento JA, et al. The first assessment of hepatitis E virus seroprevalence in northern Portugal. Acta Médica Portuguesa 1998; 11: 1065-1068.
36. Sakata H, Matsubayashi K, Takeda H, et al. A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase. Transfusion 2008; 48: 2568-2576.
37. Christensen PB, Engle RE, Hjort C, et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clinical Infectious Diseases 2008; 47: 1026-1031.
38. Galiana C, Fernandez-Barredo S, Perez-Gracia MT. Prevalence of hepatitis E virus (HEV) and risk factors in pig workers and blood donors, Enfermedades Infecciosas y Microbiología Clínica 2010; 28: 602-607.
39. Mansuy JM, Legrand-Abravanel F, Calot JP, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. Journal of Medical Virology 2008; 80: 289-293.
40. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. Journal of Clinical Microbiology 2002; 40: 117-122.
41. Lewis HC, Boisson S, Ijaz S, et al. Hepatitis E in England and Wales. Emerging Infectious Diseases 2008; 14: 165-167.
42. Teshale EH, Hu DJ, Holmberg SD. The two faces of hepatitis E virus. Clinical Infectious Diseases 2010; 51: 328-334.
43. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012; 379: 2477-2488.
44. Khuroo MS. Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30years before and has been under surveillance since then. Hepatology International 2010; 4: 494-499.
45. Teshale EH, Grytdal SP, Howard C, et al. Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clinical Infectious Diseases 2010; 50: 1006-1010.
46. Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995; 345: 1025-1026.
47. Toyoda H, Honda T, Hayashi K, et al. Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia. Intervirology 2008; 51: 21-25.
48. Pérez-Gracia MT, Mateos-Lindemann ML. Hepatitis E. Current perspectives. Medicine Clínica (Barcelona) 2012; 139: 404-411.
49. Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. Transfusionassociated hepatitis E, France. Emerging Infectious Diseases 2007; 13: 648-649.
50. Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004; 44: 934-940.
51. Siddiqui AR, Jooma RA, Smego RA. Nosocomial outbreak of hepatitis E infection in Pakistan with possible parenteral transmission. Clinical Infectious Diseases 2005; 40: 908-909.
52. Khuroo MS, Kamili S. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. Journal of Viral Hepatitis 2009; 16: 519-523.
53. Psichogiou M, Tzala E, Boletis J, et al. Hepatitis E virus infection in individuals at high risk of transmission of non-A, non-B hepatitis and sexually transmitted diseases. Scandinavian Journal of Infectious Diseases 1996; 28: 443-445.
54. Colson P, Borentain P, Queyriaux, B, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. Journal of Infectious Diseases 2010; 202: 825-834.
55. Masuda J, Yano K, Tamada Y, et al. Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan. Hepatology Research 2005; 31: 178-183.
56. Dalton HR, Fellows HJ, Gane EJ, et al. Hepatitis E in New Zealand. Journal of Gastroenterology and Hepatology 2007; 22: 1236-1240.
57. Aggarwal R, Kini D, Sofat S, et al. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 2000; 356: 1081-1082.
58. Dalton HR, Stableforth W, Thurairajah P, et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. European Journal of Gastroenterology and Hepatology 2008; 20: 784-790.
59. Dalton HR, Bendall RP, Rashid M, et al. Host risk factors and autochthonous hepatitis E infection. European Journal of Gastroenterology and Hepatology 2011; 23: 1200-1205.
60. Hussaini SH, Skidmore SJ, Richardson P, Sherratt LM, Cooper BT, O'Grady JG. Severe hepatitis E infection during pregnancy. Journal of Viral Hepatitis 1997; 4: 51-54.
61. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver International 2008; 28: 1190-1199.
62. Davern TJ, Chalasami N, Fontana RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011; 41: 1665-1672.
63. Peron JM, Danjoux M, Kamar N, et al. Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from southwest France. Virchows Archiv 2007; 450: 405-410.
64. Malcolm P, Dalton H, Hussaini HS, et al. The histology of acute autochthonous hepatitis E virus infection. Histopathology 2007; 51: 190-194.
65. Hoerning A, Hegen B, Wingen AM, et al. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients - a single-center experience. Pediatric Transplantation 2012; 16: 742-747.
66. González Tallón AI, Moreira Vicente V, Mateos Lindemann ML, et al. Hepatitis crónica E en paciente inmunocompetente. Gastroenterología y Hepatología 2011; 34: 398-400.
67. Motte A, Roquelaure B, Galambrun C, et al. Hepatitis E in three inmunocompromized children in south-east France. Journal of Clinical Virology 2012; 53: 162-166.
68. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481-1489
69. Dalton HR, Bendall RP, Keane FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. New England Journal of Medicine 2009; 361: 1025-1027.
70. Abravanel F, Mansuy JM, Huynh A, et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. Journal of Clinical Virology 2012; 54: 152-155.
71. Kamar N, Izopet J, Rostaing L. No reactivation of hepatitis E virus after kidney retransplantation. American Journal of Transplantation 2012; 12: 507-508.
72. Kamar N, Mansuy JM, Cointault O, et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. American Journal of Transplantation 2008; 8: 1744-1748.
73. Haagsma EB, van den Berg AP, Porte RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transplantation 2008; 14: 547-553.
74. Kumar Acharya S, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. Journal of Hepatology 2007; 46: 387-394.
75. Dalton H, Bendall R, Ijaz S, et al. Hepatitis E: an emerging infection in developed countries. The Lancet Infectious Diseases 2008; 8: 698-709.
76. Peron JM, Dalton H, Izopet J, et al. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? Journal of Hepatology 2011; 54: 1323-1324, author reply 1324-1325.
77. Thapa R, Biswas B, Mallick D, et al. Acute pancreatitis complicating hepatitis E virus infection in a 7-year-old boy with glucose 6 phosphate dehydrogenase deficiency. Clinical Pediatrics (Philadelphia) 2009; 48: 199-201.
78. Singh NK, Gangappa M. Acute immune thrombocytopenia associated with hepatitis E in an adult. American Journal of Hematology 2007; 82: 942-943.
79. Ali G, Kumar M, Bali SK, et al. Hepatitis E associated immune trombocitopenia and membranous glomerulonephritis. Indian Journal of Nephrology 2001; 11: 70-72.
80. Thapa R, Mallick D, Biswas B. Henoch Schonlein purpura triggered by acute hepatitis E virus infection. The Journal of Emergency Medicine 2010; 39: 218-219.
81. Kamar N, Izopet J, Cintas P, et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. American Journal of Transplantation 2010; 10: 1321-1324.
82. Bhatia V, Singhal A, Panda SK, et al. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology 2008; 48: 1577-1585.
83. Renou C, Pariente A, Nicand E, et al. Pathogenesis of hepatitis E in pregnancy. Liver International 2008; 28: 1465; author reply 1466.
84. Mateos Lindemann ML, Gabilondo G, Romero B, et al. Low prevalence of hepatitis E infection among pregnant women in Madrid, Spain. Journal of Medical Virology 2010; 82: 1666-1668.
85. Le Coutre P, Meisel H, Hofmann J, et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009; 58: 699-702.
86. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. New England Journal of Medicine 2008; 358: 811-817.
87. Mateos-Lindemann ML, Gonzalez-Galdámez A, Bordallo-Cardona M, Pérez-Gracia MT. Are HIV-infected patients a high-risk population for hepatitis E virus infection in Spain? Enfermedades Infecciosas y Microbiología Clínica 2012; 30: 582-583.
88. Madejon A, Vispo E, Bottecchia M, et al. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. Journal of Viral Hepatitis 2009; 16: 895-896.
89. Colson P, Dhiver C, Gerolami R. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection. Clinical Microbiology and Infection 2008; 14: 1176-1180.
90. Thoden J, Venhoff N, Miehle N, et al. Hepatitis E and jaundice in an HIV-positive pregnant woman. AIDS 2008; 22: 909-910.
91. Bigaillon C, Tesse S, Lagathu G, et al. Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection. Journal of Virological Methods 2009; 164: 127-130.
92. Legrand-Abravanel F, Thevenet I, Mansuy JM, et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clinical and Vaccine Immunology 2009; 16: 772-774.
93. Ohnishi S, Kang JH, Maekubo H, et al. Comparison of clinical features of acute hepatitis caused by hepatitis E virus (HEV) genotypes 3 and 4 in Sapporo, Japan. Hepatology Research 2006; 36: 301-307.
94. Aggarwal R. Clinical presentation of hepatitis E. Virus Research 2011; 161: 15-22.
95. Jothikumar N, Cromeans TL, Robertson BH, et al. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. Journal of Virological Methods 2006; 131: 65-71.
96. Pavio N, Meng X, Renou C. Zoonotic hepatitis E: animal reservoirs and emerging risks. Veterinary Research 2010; 41: 46-66.
97. Emerson SU, Arankalle VA, Purcell RH. Thermal stability of hepatitis E virus. Journal of Infectious Diseases 2005; 192: 930-933.
98. Bouwknegt M, Engel B, Herremans MM, et al. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in the Netherlands. Epidemiology and Infection 2008; 136: 567-576.
99. Hakze-van der Honing R.W, van Coillie E, Antonis AF, et al. First isolation of hepatitis E virus genotype 4 in Europe through swine surveillance in the Netherlands and Belgium. PLoS One 2011; 6: e22673.
100. Kamar N, Abravanel F, Garrouste C, et al. Three-month pegylated interferonalpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrology, Dialysis, Transplantation 2010; 25: 2792-2795.
101. Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HG. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transplantation 2010; 16: 474-477.
102. Kamar N, Abravanel F, Selves J, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010; 89: 353-360.
103. Chaillon A, Sirinelli A, De Muret A, et al. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. The Journal of Heart and Lung Transplantation 2011; 30: 841-843.
104. Gerolami R, Borentain P, Raissouni F, et al. Treatment of severe acute hepatitis E by ribavirin. Journal of Clinical Virology 2011; 52: 60-62.
105. Dalton HR, Keane FE, Bendall R, et al. Treatment of chronic hepatitis E in a patient with HIV infection. Annals of Internal Medicine 2011; 155: 479-480.
106. Mallet V, Nicand E, Sultanik P, et al. Communication: case reports of ribavirin treatment for chronic hepatitis E. Annals of Internal Medicine 2010; 153: 85-89.
107. Purcell RH, Nguyen H, Shapiro M, et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 2003; 21: 2607-2615.
108. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. New England Journal of Medicine 2007; 356: 895-903.
109. Li SW, Zhang J, Li YM, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005; 23: 2893-2901.
110. Zhang J, Liu CB, Li RC, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 2009; 27: 1869-1874.
111. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376: 895-902.
112. Park SB. Hepatitis E vaccine debuts. Nature 2012; 491: 21-22.
113. Chandra NS, Rai RR, Malhotra B. Phylogenetic analysis of hepatitis e virus in northwest India. Hepatitis Research and Treatment 2012; 2012: 976434.
114. Pina S, Jofre J, Emerson SU, Purcell RH, et al. Characterization of a strain of infectious hepatitis E virus isolated from sewage in an area where hepatitis E is not endemic. Applied and Environmental Microbiology 1998; 64: 4485-4488.
115. Gouvea V, Snellings N, Cohen SJ, et al. Hepatitis E virus in Nepal: similarities with the Burmese and Indian variants. Virus Research 1997; 52: 87-96.
116. Takahashi K, Kang JH, Ohnishi S, et al. Genetic heterogeneity of hepatitis E virus recovered from Japanese patients with acute sporadic hepatitis. Journal of Infectious Diseases 2002; 185: 1342-1345.
117. Van Cuyck-Gandre H, Zhang HY, Tsarev SA, et al. Short report: phylogenetically distinct hepatitis E viruses in Pakistan. The American Journal of Tropical Medicine and Hygiene 2000; 62: 187-189.
118. Villalba Mde, Lay Lde L, Chandra V, et al. Hepatitis E virus genotype 1, Cuba. Emerging Infectious Diseases 2008; 14: 1320-1322.
119. Aye TT, Uchida T, Ma XZ, et al. Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Research 1992; 20: 3512.
120. Drabick JJ, Gambel JM, Gouvea VS, et al. A cluster of acute hepatitis E infection in United Nations Bangladeshi peacekeepers in Haiti. The American Journal of Tropical Medicine and Hygiene 1997; 57: 449-454.
121. Lu L, Drobeniuc J, Kobylnikov N, et al. Complete sequence of a Kyrgyzstan swine hepatitis E virus (HEV) isolated from a piglet thought to be experimentally infected with human HEV. Journal of Medical Virology 2004; 74: 556-562.
122. Meng J, Cong M, Dai X, et al. Primary structure of open reading frame 2 and 3 of the hepatitis E virus isolated from Morocco. Journal of Medical Virology 1999; 57: 126-133.
123. Van Cuyck-Gandre H, Zhang HY, Tsarev SA, et al. Characterization of hepatitis E virus (HEV) from Algeria and Chad by partial genome sequence. Journal of Medical Virology 1997; 53: 340-347.
124. He J, Binn LN, Tsarev SA, et al. Molecular characterization of a hepatitis E virus isolate from Namibia. Journal of Biomedical Science 2000; 7: 334-338.
125. Huang CC, Nguyen D, Fernandez J, et al. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology 1992; 191: 550-558.
126. Maila HT, Bowyer SM, Swanepoel R. Identification of a new strain of hepatitis E virus from an outbreak in Namibia in 1995. Journal of General Virology 2004; 85: 89-95.
127. Lu YH, Qian HZ, Qin X, et al. Subtypes of genotype 3 hepatitis E virus in pigs. Veterinary Journal 2013. pii: S1090-0233(12)00550-3. doi: 10.1016/j.tvjl.2012.12.023.
128. de la Caridad Montalvo Villalba M, Owot JC, Corrreia B, et al. Hepatitis E virus genotype 3 in humans and swine, Cuba. Infection, Genetics and Evolution 2013; 14: 335-339.
129. Nidaira M, Takahashi K, Ogura G, et al. Detection and phylogenetic analysis of hepatitis E viruses from mongooses in Okinawa, Japan. Journal of Veterinary Medical Science 2012; 74: 1665-1668.
130. Wenzel JJ, Preiss J, Schemmerer M, et al. Detection of hepatitis E virus (HEV) from porcine livers in Southeastern Germany and high sequence homology to human HEV isolates. Journal of Clinical Virology 2011; 52: 50-54.
131. Takahashi K, Kitajima N, Abe N, et al. Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology 2004; 330: 501-505.
132. Renou C, Pariente A, Cadranel JF, et al. Clinically silent forms may partly explain the rarity of acute cases of autochthonous genotype 3c hepatitis E infection in France. Journal of Clinical Virology 2011; 51: 139-141.
133. Wu JC, Chen CM, Chiang TY, et al. Spread of hepatitis E virus among different-aged pigs: two year survey in Taiwan. Journal of Medical Virology 2002; 66: 488-492.
134. Wiratsudakul A, Sariya L, Prompiram P, et al. Detection and phylogenetic characterization of hepatitis E virus genotype 3 in a captive wild boar in Thailand. Journal of Zoo and Wildlife Medicine 2012; 43: 640-644.
135. Nakano T, Okano H, Kobayashi M, et al. Molecular epidemiology and genetic history of European-type genotype 3 hepatitis E virus indigenized in the central region of Japan. Infection, Genetics and Evolution 2012; 12: 1524-1534.
136. Clemente-Casares P, Pina S, Buti M, et al. Hepatitis E virus epidemiology in industrialized countries. Emerging Infectious Diseases 2003; 9: 448-454.
137. Keawcharoen J, Thongmee T, Panyathong R, et al. Hepatitis E virus genotype 3f sequences from pigs in Thailand, 2011-2012. Virus Genes 2013; 46: 369-370.
138. Luciano L, Martel C, De Pina JJ, et al. Genotype 3f predominance in symptomatic acute autochthonous hepatitis E: a short case series in south-eastern France. Clinics and Research in Hepatology and Gastroenterology 2012; 36: e54-55.
139. Kaba M, Davoust B, Cabre O, et al. Hepatitis E virus genotype 3f in pigs in New Caledonia. Australian Veterinary Journal 2011; 89: 496-499.
140. Mirazo S, Ramos N, Russi JC, et al. Genetic heterogeneity and subtyping of human Hepatitis E virus isolates from Uruguay. Virus Research 2013. pii: S0168-1702(13)00006-3. doi: 10.1016/j.virusres.2013.01.005.
141. Dell'Amico MC, Cavallo A, Gonzales JL, et al. Hepatitis E virus genotype 3 in humans and Swine, Bolivia. Emerging Infectious Diseases 2011; 17: 1488-1490.
142. Pei Y, Yoo D. Genetic characterization and sequence heterogeneity of a Canadian isolate of swine hepatitis E virus. Journal of Clinical Microbiology 2002; 40: 4021-4029.
143. Liu P, Li L, Wang L, et al. Phylogenetic analysis of 626 hepatitis E virus (HEV) isolates from humans and animals in China (1986-2011) showing genotype diversity and zoonotic transmission. Infection, Genetics and Evolution 2012; 12: 428-434.
144. Garbuglia AR, Scognamiglio P, Petrosillo N, et al. Hepatitis E virus genotype 4 outbreak, Italy, 2011. Emerging Infectious Diseases 2013; 19: 110-114.
145. Begum N, Polipalli SK, Husain SA, et al. Molecular analysis of swine hepatitis E virus from north India. Indian Journal of Medical Research 2010; 132: 504-508.
146. Hijikata M, Hayashi S, Trinh NT, et al. Genotyping of hepatitis E virus from Vietnam. Intervirology 2002; 45: 101-104.
147. Wichmann O, Schimanski S, Koch J, et al. Phylogenetic and case-control study on hepatitis E virus infection in Germany. Journal of Infectious Diseases 2008; 198: 1732-1741.
148. Liu Z, Chi B, Takahashi K, Mishiro S. A genotype 4 hepatitis E virus strain that may be indigenous to Changchun, China. Intervirology 2003; 46: 252-256.